By exploring the mechanisms of UPS action in TIME and its role in PD-1/PD-L1 expression and stability, we can better leverage these targets to develop novel therapeutic strategies, enhancing the efficacy of cancer treatment and improving patient survival outcomes. Here, PDCD1 is linked to cancer.